跳至主要内容
临床试验/JPRN-UMIN000054127
JPRN-UMIN000054127尚未招募Unknown

A multicenter observational study to evaluate the efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in patients with unresectable neuroendocrine tumors (NEN). - A multicenter observational study to evaluate the efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in patients with unresectable neuroendocrine tumors (NEN).

ational cancer center0 个研究点目标入组 200 人开始时间: 2024年4月12日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
200